ARV-825一种BRD4抑制剂,对BRD4的BD1和BD2结构域具有高亲和力,Kd值分别为90和28nM。ARV-825 is a PROTAC (proteolysis-targeting chimera). ARV-825 exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells. Co-treat